Thomas Moriarty - 01 Apr 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP & General Counsel
Signature
/s/ Thomas M. Moriarty
Issuer symbol
CVS
Transactions as of
01 Apr 2022
Net transactions value
-$6,331,570
Form type
4
Filing time
05 Apr 2022, 19:39:08 UTC
Previous filing
17 Mar 2022
Next filing
30 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability $10,700,781 -105,854 -13% $101.09 730,897 01 Apr 2022 Direct F1
transaction CVS Common Stock Tax liability $359,476 -3,556 -0.48% $101.09 735,349 03 Apr 2022 Direct F2
holding CVS Common Stock 81,179 01 Apr 2022 By GRAT
holding CVS Stock Unit 46,519 01 Apr 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $4,728,687 +46,777 $101.09 46,777 01 Apr 2022 Common Stock 46,777 $101.09 Direct F3
holding CVS Stock Option 71,696 01 Apr 2022 Common Stock 71,696 $104.82 Direct F4
holding CVS Stock Option 125,224 01 Apr 2022 Common Stock 125,224 $78.05 Direct F5
holding CVS Stock Option 36,490 01 Apr 2022 Common Stock 36,490 $62.21 Direct F6
holding CVS Stock Option 101,004 01 Apr 2022 Common Stock 101,004 $54.19 Direct F7
holding CVS Stock Option 147,837 01 Apr 2022 Common Stock 147,837 $58.34 Direct F8, F9
holding CVS Stock Option 155,495 01 Apr 2022 Common Stock 155,495 $74.30 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs.
F2 Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022.
F3 Option becomes exercisable in four equal annual installments, commencing 4/1/2023.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F5 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F7 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F8 The number of shares subject to the option were calculated using a 30-day average price.
F9 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F10 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.